{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T23:06:01Z","timestamp":1750892761141},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,30]],"date-time":"2013-01-30T00:00:00Z","timestamp":1359504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00108-012-3230-3","type":"journal-article","created":{"date-parts":[[2013,1,28]],"date-time":"2013-01-28T04:25:26Z","timestamp":1359347126000},"page":"254-262","source":"Crossref","is-referenced-by-count":6,"title":["Palliative Schmerztherapie"],"prefix":"10.1007","volume":"54","author":[{"given":"H.","family":"Cuhls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Brunsch-Radbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Schmidt-Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rolke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"3230_CR1","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S et\u00a0al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13:e58\u2013e68","journal-title":"Lancet Oncol"},{"key":"3230_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/1049909107312597","volume":"25","author":"Chhabra","year":"2008","unstructured":"Chhabra S, Bull J (2008) Methadone. Am J Hosp Palliat Care 25:146\u2013150","journal-title":"Am J Hosp Palliat Care"},{"key":"3230_CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0924-977X(03)00146-9","volume":"14","author":"Davids","year":"2004","unstructured":"Davids E, Gastpar M (2004) Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol 14:209\u2013216","journal-title":"Eur Neuropsychopharmacol"},{"key":"3230_CR4","doi-asserted-by":"crossref","unstructured":"Dean M (2004) Opioids in renal failure and dialysis patients. J\u00a0Pain Symptom Manage 28:497\u2013504","DOI":"10.1016\/j.jpainsymman.2004.02.021"},{"key":"3230_CR5","doi-asserted-by":"crossref","unstructured":"Donner B, Zenz M, Strumpf M et\u00a0al (1998) Long-term treatment of cancer pain with transdermal fentanyl. J\u00a0Pain Symptom Manage 15:168\u2013175","DOI":"10.1016\/S0885-3924(97)00361-8"},{"key":"3230_CR6","doi-asserted-by":"crossref","unstructured":"Fine PG, Portenoy RK, Revie AHEPE (2009) Establishing \u201eBest Practices\u201c for opioid rotation: conclusions of an expert panel. J\u00a0Pain Symptom Manage 38:418\u2013425","DOI":"10.1016\/j.jpainsymman.2009.06.002"},{"key":"3230_CR7","doi-asserted-by":"crossref","unstructured":"Kocsis P, Farkas S, Fodor L et\u00a0al (2005) Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J\u00a0Pharmacol Exp Ther 315:1237\u20131246","DOI":"10.1124\/jpet.105.089805"},{"key":"3230_CR8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00108-011-2902-8","volume":"53","author":"Laufenberg-Feldmann","year":"2012","unstructured":"Laufenberg-Feldmann R, Schwab R, Rolke R et\u00a0al (2012) Cancer pain in palliative medicine. Der Internist 53:177\u2013190","journal-title":"Der Internist"},{"key":"3230_CR9","first-page":"115","volume":"2","author":"Likar","year":"2006","unstructured":"Likar R (2006) Transdermal buprenorphine in the management of persistent pain \u2013 safety aspects. Ther Clin Risk Manag 2:115\u2013125","journal-title":"Ther Clin Risk Manag"},{"key":"3230_CR10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3959(79)90175-1","volume":"6","author":"Merskey","year":"1979","unstructured":"Merskey H, Albe-Fessard D, Bonica JJ et\u00a0al (1979) Pain terms: a list with definitions and notes on usage. Recommended by IASP subcommittee on taxonomy. Pain 6:249\u2013252","journal-title":"Pain"},{"key":"3230_CR11","doi-asserted-by":"crossref","unstructured":"Nauck F, Eulitz N, Geyer A et\u00a0al (2008) Durchbruchschmerzen: Epidemiologie, Charakteristik und Therapie unter Ber\u00fccksichtigung verschiedener Applikationsformen starker Opioide. Z\u00a0Palliativmed 9:219\u2013237","DOI":"10.1055\/s-0028-1090095"},{"key":"3230_CR12","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1345\/aph.1Q748","volume":"46","author":"Nelson","year":"2012","unstructured":"Nelson EM, Philbrick AM (2012) Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors (December). Ann Pharmacother 46:1712\u20131716","journal-title":"Ann Pharmacother"},{"key":"3230_CR13","first-page":"CD003971","volume":"Rev","author":"Nicholson","year":"2007","unstructured":"Nicholson AB (2007) Methadone for cancer pain. Cochrane Database Syst Rev:CD003971","journal-title":"Cochrane Database Syst"},{"key":"3230_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000542-199301000-00007","volume":"78","author":"Portenoy","year":"1993","unstructured":"Portenoy RK, Southam MA, Gupta SK et\u00a0al (1993) Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics. Anesthesiology 78:36\u201343","journal-title":"Anesthesiology"},{"key":"3230_CR15","first-page":"1","volume":"2","author":"Rolke","year":"2010","unstructured":"Rolke R, Birklein F (2010) Neuropathische Komponente bei Tumorschmerzen: Ein Leitfaden f\u00fcr Diagnostik und Therapie. Angew Schmerzther Palliativmed 2:1\u201310","journal-title":"Angew Schmerzther Palliativmed"},{"key":"3230_CR16","doi-asserted-by":"crossref","unstructured":"Simon ST, Muller-Busch C, Bausewein C (2011) Symptom management of pain and breathlessness. Internist (Berl) 52:28, 30\u201335","DOI":"10.1007\/s00108-010-2692-4"},{"key":"3230_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s004820050197","volume":"13","author":"Tegeder","year":"1999","unstructured":"Tegeder I, Geisslinger G, Lotsch J (1999) Therapy with opioids in liver or renal failure. Schmerz 13:183\u2013195","journal-title":"Schmerz"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3230-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-012-3230-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3230-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T19:27:28Z","timestamp":1562614048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-012-3230-3"}},"subtitle":["Aktuelle Aspekte der Arzneimitteltherapie"],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["3230"],"URL":"https:\/\/doi.org\/10.1007\/s00108-012-3230-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,30]]}}}